Abstract
Introduction
Lymphomatosis cerebri (LC) is a rare variant of primary central nervous system lymphoma that diffusely involves throughout the brain. In recent years, increasingly reported cases have notably broadened the spectrum of clinical and radiological features; however, it remains a great diagnostic challenge.
Case report
We reported an atypical case of LC presented with subacute onset of focal neurological deficits and diffuse T2 hyperintensities without contrast enhancement on magnetic resonance imaging. He was initially considered as inflammatory leukoencephalopathy and received empirical corticosteroids, showing a dramatically clinical response. Three months later, the patient relapsed with deteriorating symptoms and enlarged brain lesions with mass-like enhancement. A diagnosis of LC was finally established according to the radiological and pathological findings.
Discussion
Though rare, LC should always be kept as a differential diagnosis of diffuse leukoencephalopathy. Neurologists should be aware of every detailed information about LC to avoid a delay of diagnostic biopsy in clinical practice.
References
Bakshi R, Mazziotta JC, Mischel PS et al (1999) Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord 10:152–157. https://doi.org/10.1159/000017116
Yeh WZ, Muthusamy S, McKelvie P et al (2020) Lymphoma, a great imitator in neurology. J Clin Neurosci 73:308–310. https://doi.org/10.1016/j.jocn.2020.02.001
Izquierdo C, Velasco R, Vidal N et al (2016) Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature. Neuro Oncol 18:707–715. https://doi.org/10.1093/neuonc/nov197
Kerbauy MN, Pasqualin D, Smid J et al (2019) Diffuse large B-cell lymphoma of the central nervous system presenting as “lymphomatosis cerebri” and dementia in elderly man: case report and review of the literature. Medicine (Baltimore) 98:e14367. https://doi.org/10.1097/MD.0000000000014367
Yamada SM, Tomita Y, Takahashi M et al (2022) A case of lymphomatosis cerebri presenting with rapid progression of dementia: a literature review. NMC Case Rep J 9:83–88. https://doi.org/10.2176/jns-nmc.2021-0125
Li L, Rong JH, Feng J (2018) Neuroradiological features of lymphomatosis cerebri: a systematic review of the English literature with a new case report. Oncol Lett 16:1463–1474. https://doi.org/10.3892/ol.2018.8839
Kobayashi Z, Sakai S, Itaya S et al (2021) Distribution of deep gray matter lesions on magnetic resonance imaging in lymphomatosis cerebri. Intern Med 60:623–627. https://doi.org/10.2169/internalmedicine.5200-20
Ruan Z, Chu L, Liu C, Hu Y et al (2021) Lymphomatosis cerebri: multimodality imaging features and misdiagnosis analysis. Oncol Lett 22:701. https://doi.org/10.3892/ol.2021.12962
Samani A, Davagnanam I, Cockerell OC et al (2015) Lymphomatosis cerebri: a treatable cause of rapidly progressive dementia. J Neurol Neurosurg Psychiatry 86:238–240. https://doi.org/10.1136/jnnp-2013-307327
Kawai N, Miyake K, Yamamoto Y et al (2013) 18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma. Biomed Res Int 2013:247152. https://doi.org/10.1155/2013/247152
Patra A, Jasper A, Vanjare H et al (2021) Diffuse infiltrative non-mass-like brain parenchymal lesions on MRI: differentiating lymphomatosis cerebri from its mimics. J Clin Imaging Sci 11:41. https://doi.org/10.25259/JCIS_75_2021
Tomura N, Saginoya T, Goto H (2021) PET findings in lymphomatosis and gliomatosis of the brain: a comparison of C-11 methionine PET/CT and F-18 FDG PET/CT. Acta Radiol 62:1391–1396. https://doi.org/10.1177/0284185120966710
Hashiguchi S, Momoo T, Murohashi Y et al (2015) Interleukin 10 level in the cerebrospinal fluid as a possible biomarker for lymphomatosis cerebri. Intern Med 54:1547–1552. https://doi.org/10.2169/internalmedicine.54.3283
Imperiale D, Taraglio S, Atzori C et al (2015) Diffuse leukoencephalopathy due to lymphomatosis cerebri: a clinicopathological report. Neurol Sci 36:1071–1073. https://doi.org/10.1007/s10072-014-1974-3
Fox CP, Phillips EH, Smith J et al (2019) Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma. Br J Haematol 184:348–363. https://doi.org/10.1111/bjh.15661
Yu H, Gao B, Liu J et al (2017) Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features. Cancer Imaging 17:26. https://doi.org/10.1186/s40644-017-0128-2
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
No identifiable information was disclosed in writing this case report; further ethical board approval was waived in accordance with local regulations.
Informed consent
Written consent was obtained from the patient’s family for publishing his medical data for scientific purposes.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, YX., Tang, JL. & Lai, QL. Lymphomatosis cerebri: a rare diffuse leukoencephalopathy you should never miss. Neurol Sci 43, 6961–6965 (2022). https://doi.org/10.1007/s10072-022-06416-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06416-x